Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 6201 [2018-02900]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 30 / Tuesday, February 13, 2018 / Notices
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
on March 2, 2018, for the Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria (Advisory
Council). The meeting will be open to
the public via teleconference; a public
comment session will be held during
the meeting. Pre-registration is required
for members of the public who wish to
attend the meeting via teleconference
and who wish to participate in the
public comment session. Individuals
who wish to send in their public
comment via email should send an
email to CARB@hhs.gov. Registration
information is available on the website
https://www.hhs.gov/ash/carb/ and must
be completed by February 26, 2018.
Additional information about registering
for the meeting and providing public
comment can be obtained at https://
www.hhs.gov/ash/carb/ on the Meetings
page.
SUMMARY:
The meeting is scheduled to be
held on March 2, 2018, from 9:00 a.m.
to 11:00 a.m. ET (times are tentative and
subject to change). The confirmed times
and agenda items for the meeting will be
posted on the website for the Advisory
Council at https://www.hhs.gov/ash/
carb/ when this information becomes
available. Pre-registration for attending
the meeting is required to be completed
no later than February 26, 2018.
DATES:
Instructions regarding
attending this meeting will be posted
one week prior to the meeting at: https://
www.hhs.gov/ash/carb/.
ADDRESSES:
sradovich on DSK3GMQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, Acting Designated
Federal Officer, Presidential Advisory
Council on Combating AntibioticResistant Bacteria, Office of the
Assistant Secretary for Health, U.S.
Department of Health and Human
Services, Room 715H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW, Washington, DC 20201.
Phone: (202) 690–5566; email: CARB@
hhs.gov.
VerDate Sep<11>2014
23:12 Feb 12, 2018
Jkt 244001
Under
Executive Order 13676, dated
September 18, 2014, authority was given
to the Secretary of HHS to establish the
Advisory Council, in consultation with
the Secretaries of Defense and
Agriculture. Activities of the Advisory
Council are governed by the provisions
of Public Law 92–463, as amended (5
U.S.C. App.), which sets forth standards
for the formation and use of federal
advisory committees.
The Advisory Council will provide
advice, information, and
recommendations to the Secretary of
HHS regarding programs and policies
intended to support and evaluate the
implementation of Executive Order
13676, including the National Strategy
for Combating Antibiotic-Resistant
Bacteria and the National Action Plan
for Combating Antibiotic-Resistant
Bacteria. The Advisory Council shall
function solely for advisory purposes.
In carrying out its mission, the
Advisory Council will provide advice,
information, and recommendations to
the Secretary regarding programs and
policies intended to preserve the
effectiveness of antibiotics by
optimizing their use; advance research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance.
The public meeting will be dedicated
to the Advisory Council’s deliberation
and vote on a letter drafted by the
Immediate Action Subcommittee. The
meeting agenda will be posted on the
Advisory Council website at https://
www.hhs.gov/ash/carb/ when it has
been finalized. All agenda items are
tentative and subject to change.
Instructions regarding attending this
meeting will be posted one week prior
to the meeting at: https://www.hhs.gov/
ash/carb/.
Members of the public will have the
opportunity to provide comments prior
to the Advisory Council meeting by
emailing CARB@hhs.gov. Public
comments should be sent in by
midnight February 26, 2018, and should
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
6201
be limited to no more than one page. All
public comments received prior to
February 26, 2018, will be provided to
Advisory Council members; comments
are limited to two minutes per speaker.
Dated: February 7, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer,
Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Committee
Manager.
[FR Doc. 2018–02900 Filed 2–12–18; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Research
Project Grants.
Date: March 5, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7351, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–8886,
sanoviche@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK R01–A1
Telephone SEP.
Date: March 6, 2018.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Page 6201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02900]
[[Page 6201]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held on March 2, 2018, for the
Presidential Advisory Council on Combating Antibiotic-Resistant
Bacteria (Advisory Council). The meeting will be open to the public via
teleconference; a public comment session will be held during the
meeting. Pre-registration is required for members of the public who
wish to attend the meeting via teleconference and who wish to
participate in the public comment session. Individuals who wish to send
in their public comment via email should send an email to [email protected].
Registration information is available on the website https://www.hhs.gov/ash/carb/ and must be completed by February 26, 2018.
Additional information about registering for the meeting and providing
public comment can be obtained at https://www.hhs.gov/ash/carb/ on the
Meetings page.
DATES: The meeting is scheduled to be held on March 2, 2018, from 9:00
a.m. to 11:00 a.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the Advisory Council at https://www.hhs.gov/ash/carb/ when
this information becomes available. Pre-registration for attending the
meeting is required to be completed no later than February 26, 2018.
ADDRESSES: Instructions regarding attending this meeting will be posted
one week prior to the meeting at: https://www.hhs.gov/ash/carb/.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room 715H, Hubert H. Humphrey
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone:
(202) 690-5566; email: [email protected].
SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September
18, 2014, authority was given to the Secretary of HHS to establish the
Advisory Council, in consultation with the Secretaries of Defense and
Agriculture. Activities of the Advisory Council are governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets
forth standards for the formation and use of federal advisory
committees.
The Advisory Council will provide advice, information, and
recommendations to the Secretary of HHS regarding programs and policies
intended to support and evaluate the implementation of Executive Order
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating
Antibiotic-Resistant Bacteria. The Advisory Council shall function
solely for advisory purposes.
In carrying out its mission, the Advisory Council will provide
advice, information, and recommendations to the Secretary regarding
programs and policies intended to preserve the effectiveness of
antibiotics by optimizing their use; advance research to develop
improved methods for combating antibiotic resistance and conducting
antibiotic stewardship; strengthen surveillance of antibiotic-resistant
bacterial infections; prevent the transmission of antibiotic-resistant
bacterial infections; advance the development of rapid point-of-care
and agricultural diagnostics; further research on new treatments for
bacterial infections; develop alternatives to antibiotics for
agricultural purposes; maximize the dissemination of up-to-date
information on the appropriate and proper use of antibiotics to the
general public and human and animal healthcare providers; and improve
international coordination of efforts to combat antibiotic resistance.
The public meeting will be dedicated to the Advisory Council's
deliberation and vote on a letter drafted by the Immediate Action
Subcommittee. The meeting agenda will be posted on the Advisory Council
website at https://www.hhs.gov/ash/carb/ when it has been finalized. All
agenda items are tentative and subject to change.
Instructions regarding attending this meeting will be posted one
week prior to the meeting at: https://www.hhs.gov/ash/carb/.
Members of the public will have the opportunity to provide comments
prior to the Advisory Council meeting by emailing [email protected]. Public
comments should be sent in by midnight February 26, 2018, and should be
limited to no more than one page. All public comments received prior to
February 26, 2018, will be provided to Advisory Council members;
comments are limited to two minutes per speaker.
Dated: February 7, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2018-02900 Filed 2-12-18; 8:45 am]
BILLING CODE 4150-44-P
